Topical Collection on Cardiometabolic Disease and Treatment
In this topical collection (25 articles)
-
Cardiovascular Disease and Stroke (J.A. Underberg and J. Newman, Section Editors)
Obesity Management in Cardiometabolic Disease: State of the Art
Sean J. Iwamoto, Layla A. Abushamat, Adnin Zaman… Article:59 -
Cardiometabolic Disease and Treatment (E. Brinton, Section Editor)
Lipoprotein (a): When to Measure and How to Treat?
David Rhainds, Mathieu R. Brodeur, Jean-Claude Tardif Article:51 -
Cardiometabolic Disease and Treatment (E. Brinton, Section Editor)
Cardiovascular Disease Risk Reduction in Mild-Moderate Hypertriglyceridemia: Integrating Prescription of Omega-3 with Standard Treatment
Fabien Picard, Philippe Gabriel Steg Article:27 -
Cardiometabolic Disease and Treatment (E. Brinton, Section Editor)
ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets
Ioannis Akoumianakis, Evangelia Zvintzou… Article:20 -
Cardiometabolic Disease and Treatment (E. Brinton, Section Editor)
Preventing Diabetes and Atherosclerosis in the Cardiometabolic Syndrome
Muhammad Imtiaz Ahmad, Michael D. Shapiro Article:16 -
Cardiometabolic Disease and Treatment (E.A. Brinton, Section Editor)
Beta-blockers for Atherosclerosis Prevention: a Missed Opportunity?
Michal Vrablik, Alberto Corsini, Eva Tůmová Pages 161-169 -
ReviewPaper
Update on Sitosterolemia and Atherosclerosis
Viviane Zorzanelli Rocha, Mauricio Teruo Tada… Pages 181-187 -
Cardiometabolic Disease and Treatment (R. Santos, Section Editor)
Genetic and Mechanistic Insights into the Modulation of Circulating Lipoprotein (a) Concentration by Apolipoprotein E Isoforms
Kévin Chemello, Dirk J. Blom, A. David Marais… Pages 399-405 -
Cardiometabolic Disease and Treatment (R. Santos, Section Editor)
Updates on the Use of Subclinical Atherosclerosis to Predict Risk of Cardiovascular Events in Heterozygous Familial Hypercholesterolemia
Antonio Gallo, Reed Mszar, Marcio Hiroshi Miname Pages 407-418 -
Cardiometabolic Disease and Treatment (R. Santos, Section Editor)
Monogenic Versus Polygenic Forms of Hypercholesterolemia and Cardiovascular Risk: Are There Any Differences?
Erin Jacob, Robert A. Hegele Pages 419-426 -
Cardiometabolic Disease and Treatment (R. Santos, Section Editor)
Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime?
Rodrigo Alonso, Rosa Argüeso, Pilar Álvarez-Baños… Pages 427-434 -
Cardiometabolic Disease and Treatment (R. Santos, Section Editor)
Glycated Hemoglobin as an Integrator of Cardiovascular Risk in Individuals Without Diabetes: Lessons from Recent Epidemiologic Studies
Alexander P. Hoffmann, Michael C. Honigberg Pages 435-442 -
ReviewPaper
Do Triglyceride-Rich Lipoproteins Equal Low-Density Lipoproteins in Risk of ASCVD?
Benjamin N. Wadström, Anders B. Wulff… Pages 795-803 -
ReviewPaper
Updates in Small Interfering RNA for the Treatment of Dyslipidemias
S. Carugo, C. R. Sirtori, G. Gelpi, A. Corsini… Pages 805-817
Continue reading...
To view the rest of this content please follow the download PDF link above.